PW Medtech Group Limited (FRA:PWE)

Market Cap	188.18M +8.8%
Revenue (ttm)	100.28M +7.1%
Net Income	11.49M -37.4%
EPS	0.01 -36.1%
Shares Out	n/a
PE Ratio	16.37
Forward PE	n/a
Dividend	0.01 (9.34%)
Ex-Dividend Date	Nov 3, 2025

Volume	n/a
Average Volume	n/a
Open	0.1140
Previous Close	0.1140
Day's Range	0.1140 - 0.1140
52-Week Range	0.0930 - 0.1830
Beta	n/a
RSI	57.68
Earnings Date	Mar 27, 2026

About PW Medtech Group

PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, and internationally. It operates through three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company manufactures and sells infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical device...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 1997
• Employees: 1,356
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: PWE

Financial Performance

In 2025, PW Medtech Group's revenue was 823.51 million, an increase of 7.10% compared to the previous year's 768.90 million. Earnings were 94.37 million, a decrease of -37.41%.

Financial numbers in CNY